Atlas Trials

Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

Clinical trial NCT03920722 · COMPLETED

Trial details

NCT number
NCT03920722
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Microscopic Polyangiitis (MPA)
Start date
2020-10-24
Primary completion
2023-09-06
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.